SIRT1 and Parkinson disease: Our results further indicate that SIRT1 can affect cell cycle and apoptosis by regulating TET2 in PD progression, and targeted downregulation or inhibition of TET2 enzyme activity could be developed as a therapeutic intervention for PD, which warrants further investigation.